Embla Medical hf: Final Agenda and Proposals for the 2026 Annual General Meeting
Announcement no. 11/2026
24 February 2026
Reykjavik, Iceland/Copenhagen, Denmark, February 24, 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced the final agenda and proposals for the Company’s 2026 Annual General Meeting, which will be held on Tuesday 10 March 2026 at 9:00 AM (GMT) at the Company’s headquarters at Grjótháls 1-5, Reykjavík, Iceland.
The final agenda can be found enclosed with this announcement. No changes have been made to the previously announced agenda and proposals.
Further information
Klaus Sindahl, Head of Investor Relations, [email protected], +45 5363 0134
Embla Medical press releases by e-mail
If you wish to receive Embla Medical press releases by e-mail, please register at http://www.emblamedical.com/investors
About Embla Medical
Embla Medical (Nasdaq Copenhagen: EMBLA) is a leading global provider of innovative mobility solutions that help people live a Life Without Limitations®. Embla Medical is home to several leading brands renowned for positively impacting people's health and well-being. They include Össur, a leading global provider of prosthetics and bracing solutions; Fior & Gentz, an innovative developer of neuro orthotics; College Park, a provider of lower limb prosthetics; and ForMotion, a global network of Orthotic and Prosthetic (O&P) patient care facilities. Embla Medical is committed to sustainable business practices, is a signatory to the UN Global Compact and UN Women’s Empowerment Principles and contributes to the UN Sustainable Development Goals. The company's climate targets have been verified by the Science Based Targets initiative. Embla Medical operates globally and has around 4,500 employees. www.emblamedical.com